Purdue Pharma L.P.
Case Number:
7:19-bk-23649
Court:
Nature of Suit:
Firms
- Brown & Connery
- Bielli & Klauder
- Tarter Krinsky
- Teitelbaum Law Group
- Hagens Berman
- Simmons Hanly
- Debevoise & Plimpton
- Godfrey & Kahn
- Motley Rice
- Himes Petrarca
- Wachtell Lipton
- Hurwitz Fine
- Gilbert LLP
- BatesCarey
- Lowe Stein
- Archer & Greiner
- Katsky Korins
- Brown Rudnick
- Gage Spencer & Fleming
- FBT Gibbons
- Pashman Stein
- Goodwin Procter
- Doster Ullom
- Crowell & Moring
- Morgan Lewis
- Reed Smith
- McDermott Will & Schulte
- Gertz & Rosen
- Porteous Hainkel
- Andrews & Thornton
- ArentFox Schiff
- Dentons
- Faegre Drinker
- Duane Morris
- Foley & Lardner
- Jones Day
- Davis Polk
- Porter Hedges
- Willkie Farr
- Bentley & Bruning
- ASK LLP
- Hogan Lovells
- Joseph Hage
- Marino Tortorella
- White & Case
- UB Greensfelder
- HSF Kramer
- Seyfarth Shaw
- Spangenberg Shibley
- Cuneo Gilbert
- MoloLamken
- Mintz Levin
- WestLoop Law
- Miller Nash LLP
- Blank Rome
- Kirkland & Ellis
- Cronin Fried
- Loeb & Loeb
- Phillips Lytle
- Slevin & Hart
- Doshi Legal Group
- Plevin & Turner
- Schenck Price
- Bialson Bergen
- Martin S. Rapaport
- Skadden Arps
- Saul Ewing
- Lerner Arnold
- Taft Stettinius
- Arnold & Porter
- Troutman
- Burke Warren
- Wilk Auslander
- Stutzman Bromberg
- Shook Hardy
- Sherrard Roe
- Consovoy McCarthy
- Cleary Gottlieb
- Napoli Shkolnik
- McGrail & Bensinger
- Marcus & Shapira
- Quinn Emanuel
- Pachulski Stang
- King & Spalding
- Potter Anderson
- Stevens & Lee
- Shafferman & Feldman
- Squire Patton
- Blitman & King
- Hughes Socol
- Pillsbury Winthrop
- Robins Kaplan
- WilmerHale
- Keller Rohrback
- Kobre & Kim
- Ballard Spahr
- O'Melveny & Myers
- Keller Postman
- Kleinberg Kaplan
- Clifford Law Offices
- Barack Ferrazzano
- Terrell Hogan
- Levenfeld Pearlstein
- Rothstein Mandell
- MacElree Harvey
- Klehr Harrison
- Pullman & Comley
- Mehri & Skalet
- Tate Law Group LLC
- Lowey Dannenberg
- Williams Mullen
- Waldrep Wall
- Dechert LLP
- Ifrah Law
- Seward & Kissel
- Calfee Halter
- White Coleman & Associates
- Caplin & Drysdale
- Miller Shah
- O'Brien Belland
- Binder & Schwartz
- Alston & Bird
- Akin Gump
- Carter Ledyard
- Shipman & Goodwin
- McElroy Deutsch
- Henrichsen Law Group
- Jenner & Block
- Haug Partners
- Hobbs Straus
- Latham & Watkins
- Mayer Brown
- Milbank LLP
Companies
- Teamsters Local 456
- Henry Schein Inc.
- Cencora Inc.
- Hikma Pharmaceuticals PLC
- Giant Eagle Inc.
- McKesson Corp.
- Otis Worldwide Corp.
- Liberty Mutual Insurance Group
- Bristol-Myers Squibb Co.
- Kodiak Area Native Association
- Ranbaxy
- PRA Health Sciences Inc.
- Ascent Pharmaceuticals Inc.
- Blue Cross Blue Shield Association
- Aleutian Pribilof Islands Association Inc.
- Collegium Pharmaceutical Inc.
- Endo International PLC
- Impax Laboratories, Inc.
- Omnicare Inc.
- Johnson & Johnson
- FTI Consulting Inc.
- Bausch Health Cos. Inc.
- Province LLC
- Sandoz International GmbH
- Avrio Health LP
- Nardello & Co. LLC
- DuPont de Nemours Inc.
- Hain Capital Group LLC
- United Parcel Service Inc.
- Express Scripts Holding Co.
- CVS Health Corp.
- KVK Tech Inc.
- Ironshore Inc.
- Amneal Pharmaceuticals Inc.
- Sun Pharmaceutical Industries Ltd.
- Loblaw Cos.
- Tucson Medical Center
- TR Capital Management LLC
- The Cigna Group
- Viatris Inc.
- Noramco Inc.
- Alaska Native Tribal Health Consortium
- AlixPartners LLP
- Anda Inc.
- Walmart Inc.
- AXA XL Ltd.
- Allergan PLC
- Purdue Pharma LP
- United Food & Commercial Workers International Union
- ASM Capital LP
- SAP AG
- Apria Healthcare Group
- Cardinal Health Inc.
- Arcadia Consumer Healthcare
- International Union Of Operating Engineers
- Old Republic Insurance Co.
- Oracle Corp.
- Thermo Fisher Scientific Inc.
- Verita Global LLC
- Houlihan Lokey Inc.
- American Federation of Labor & Congress of Industrial Organizations
- Jefferies Financial Group Inc.
- Teva Pharmaceutical Industries Ltd.
Government Agencies
- Pension Benefit Guaranty Corp.
- Missouri Department of Revenue
- Tennessee Attorney General's Office
- Pala Band of Mission Indians
- Seldovia Village Tribe
- Nez Perce Tribe
- Town of Ramapo, New York
- Jamestown S'Klallam Tribe
- St. Regis Mohawk Tribe
- State of Indiana
- City of Bayonne, New Jersey
- Washington State Department of Revenue
- Colorado Attorney General's Office
- Port Gamble S'Klallam Tribe
- U.S. District Court for the District of Columbia
- Borough of Paramus, New Jersey
- State of Nevada
- Northwestern Band of the Shoshone Nation
- Town of Babylon, New York
- Town of Brookhaven, New York
- New York Department of Financial Services
- Town of Hempstead, New York
- Commonwealth of Massachusetts
- Hopi Tribe
- Suquamish Tribe
- Ohio Attorney General's Office
Sectors & Industries:
-
April 16, 2020
Purdue Says Ch. 11 Stay Can't Be Lifted For NY Opioid Trial
Purdue Pharma LP on Wednesday asked a New York bankruptcy judge to reject a bid by pharmaceutical companies and pharmacies who are co-defendants in the New York opioid trial to include the OxyContin maker on the verdict form, saying that it could upset negotiations for a global settlement.
-
April 08, 2020
NY AG Seeks Additional Sackler Family Financial Info
The New York attorney general on Tuesday asked a bankruptcy court to resume discovery into the finances of the Sackler family, who owns Purdue Pharma LP, saying that her office has already unearthed important information about money transfers the family has made.
-
March 18, 2020
Purdue, Sacklers Keep Opioid Suit Shield For 6 More Months
A New York bankruptcy judge agreed on Wednesday to extend an injunction halting opioid lawsuits against Purdue Pharma LP for a further 180 days, dismissing arguments that the stay should not extend to the family that owns the drugmaker.
-
March 16, 2020
Sacklers Say Major Purdue Deal Hinges On Longer Ch. 11 Stay
The family who owns opioid maker Purdue Pharma LP asked a New York bankruptcy court Monday to extend a stay of legal action against them, arguing renewed litigation could sink a settlement that would let the company's assets be used to mitigate the national opioid crisis.
-
March 05, 2020
Purdue Wants Ch. 11 To Hold Opioid Cases At Bay Longer
Bankrupt opioid maker Purdue Pharma LP asked a New York judge late Wednesday to extend a preliminary injunction enacted in its Chapter 11 case that paused thousands of legal actions against the company for its role in the national opioid crisis.
-
March 02, 2020
Mediators To Form Plan For Purdue Ch. 11 Claims Distribution
A New York bankruptcy judge on Monday approved an order setting up mediation between government and private parties with claims in the Purdue Pharma Chapter 11 case to work out how to divide up the estate's billions of dollars in assets.
-
February 21, 2020
Purdue Picks Ex-USDA Head As Monitor In Bankruptcy
Purdue Pharma LP announced on Friday that it has tapped former U.S. Secretary of Agriculture Tom Vilsack to monitor compliance with an injunction in the OxyContin maker's ongoing Chapter 11 bankruptcy proceedings.
-
February 12, 2020
Purdue Wants To Make New Opioid Overdose Drug
Purdue Pharma LP is seeking bankruptcy court approval to begin developing an injectable treatment to reverse overdoses of fentanyl and other opioids, telling the court that time is of the essence in addressing a public health crisis that many have alleged it helped create.
-
January 24, 2020
Bankruptcy Judge OKs $1.3M Bonus For Purdue CEO
A New York bankruptcy judge ended a monthslong dispute over pay for Purdue Pharmaceutical executives Friday, saying a $1.3 million bonus for the company's CEO is reasonable for the industry.
-
January 21, 2020
Purdue, Creditors Ask To Keep Stay On Insurance Arbitration
Purdue Pharma and its unsecured creditors are asking a New York bankruptcy judge to deny an insurer's request to allow arbitration over how much product liability coverage it owes the drugmaker to proceed, saying it could severely disrupt Purdue's Chapter 11 case.